Vertex Pharmaceuticals - 29 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits. The latest closing stock price for Vertex Pharmaceuticals as of February 28, 2020 is 224.03.
  • The all-time high Vertex Pharmaceuticals stock closing price was 247.81 on February 11, 2020.
  • The Vertex Pharmaceuticals 52-week high stock price is 249.85, which is 11.5% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 163.68, which is 26.9% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 192.52.
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 233.9555 219.4500 247.8100 217.9800 224.0300 2.32%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7670 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $57.895B $4.163B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.026B 13.72
CSL (CSLLY) Australia $93.989B 0.00
Gilead Sciences (GILD) United States $91.816B 11.83
Biogen (BIIB) United States $53.974B 9.22
Regeneron Pharmaceuticals (REGN) United States $47.485B 20.11
Illumina (ILMN) United States $38.210B 39.50
Alexion Pharmaceuticals (ALXN) United States $20.389B 9.48
Seattle Genetics (SGEN) United States $18.657B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.440B 35.27
BioMarin Pharmaceutical (BMRN) United States $16.134B 690.92
Genmab (GNMSF) Denmark $14.343B 46.13
Galapagos (GLPG) Belgium $13.996B 30.57
Alnylam Pharmaceuticals (ALNY) United States $12.665B 0.00
Exact Sciences (EXAS) United States $11.959B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
BeiGene (BGNE) Cayman Islands $9.466B 0.00
Moderna (MRNA) United States $8.804B 0.00
Sarepta Therapeutics (SRPT) United States $8.374B 0.00
QIAGEN (QGEN) Netherlands $8.224B 25.33
BioNTech SE (BNTX) Germany $7.666B 0.00
Bio-Techne Corp (TECH) United States $7.402B 50.66
Guardant Health (GH) United States $7.246B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.469B 17.12
Ascendis Pharma (ASND) Denmark $6.207B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Reata Pharmaceuticals (RETA) United States $5.712B 0.00
Exelixis (EXEL) United States $5.625B 18.06
ARGENX SE-ADR (ARGX) Netherlands $5.470B 0.00
Amarin (AMRN) Ireland $5.240B 0.00
Acceleron Pharma (XLRN) United States $4.595B 0.00
China Biologic Products (CBPO) China $4.538B 25.56
Repligen (RGEN) United States $4.484B 82.00
Global Blood Therapeutics (GBT) United States $3.720B 0.00
Bluebird Bio (BLUE) United States $3.714B 0.00
Mirati Therapeutics (MRTX) United States $3.670B 0.00
Adaptive Biotechnologies (ADPT) United States $3.577B 0.00
MorphoSys AG (MOR) Germany $3.452B 0.00
Zai Lab (ZLAB) China $3.253B 0.00
Alkermes (ALKS) Ireland $3.097B 245.38
Ultragenyx Pharmaceutical (RARE) United States $3.076B 0.00
Immunomedics (IMMU) United States $3.029B 0.00
Genmab (GMAB) Denmark $3.010B 11.81
CRISPR Therapeutics AG (CRSP) Switzerland $3.008B 50.97
Blueprint Medicines (BPMC) United States $2.938B 0.00
Emergent Biosolutions (EBS) United States $2.877B 19.97
NeoGenomics (NEO) United States $2.872B 125.04
MyoKardia (MYOK) United States $2.842B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.810B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.805B 0.00
Halozyme Therapeutics (HALO) United States $2.802B 0.00
Amicus Therapeutics (FOLD) United States $2.379B 0.00
UniQure (QURE) Netherlands $2.260B 0.00
Arena Pharmaceuticals (ARNA) United States $2.210B 5.77
RA PHARMCTL INC (RARX) United States $2.193B 0.00
Fate Therapeutics (FATE) United States $2.176B 0.00
Insmed (INSM) United States $2.173B 0.00
Principia Biopharma (PRNB) United States $2.068B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Epizyme (EPZM) United States $1.864B 0.00
Denali Therapeutics (DNLI) United States $1.827B 0.00
Ligand Pharmaceuticals (LGND) United States $1.815B 53.01
Alector (ALEC) United States $1.785B 0.00
Arvinas (ARVN) United States $1.599B 0.00
Zymeworks (ZYME) Canada $1.564B 0.00
Akcea Therapeutics (AKCA) United States $1.538B 35.61
REGENXBIO (RGNX) United States $1.505B 0.00
Coherus BioSciences (CHRS) United States $1.346B 16.13
Dicerna Pharmaceuticals (DRNA) United States $1.328B 0.00
Revance Therapeutics (RVNC) United States $1.317B 0.00
Myriad Genetics (MYGN) United States $1.288B 22.74
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Zealand Pharma (ZEAL) Denmark $1.255B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.220B 0.00
Editas Medicine (EDIT) United States $1.151B 0.00
Intra-Cellular Therapies (ITCI) United States $1.135B 0.00
Twist Bioscience (TWST) United States $1.073B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.026B 0.00
Athenex (ATNX) United States $0.972B 0.00
PHARMA MAR SA (PHMMF) Spain $0.932B 0.00
DBV Technologies S.A (DBVT) France $0.912B 0.00
Mesoblast (MESO) Australia $0.859B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Cytokineticsorporated (CYTK) United States $0.824B 0.00
Adverum Biotechnologies (ADVM) United States $0.805B 0.00
Codexis (CDXS) United States $0.777B 0.00
Sangamo Therapeutics (SGMO) United States $0.773B 0.00
Heska (HSKA) United States $0.764B 0.00
Vericel (VCEL) United States $0.675B 100.07
Cellectis S.A (CLLS) France $0.672B 0.00
Arcus Biosciences (RCUS) United States $0.661B 0.00
Retrophin (RTRX) United States $0.647B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.614B 0.00
Intrexon (PGEN) United States $0.605B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.19
Anika Therapeutics (ANIK) United States $0.587B 20.06
ANI Pharmaceuticals (ANIP) United States $0.583B 10.53
Kadmon Holdings (KDMN) United States $0.578B 0.00
Intellia Therapeutics (NTLA) United States $0.568B 0.00
UROGEN PHARMA (URGN) United States $0.559B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.541B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.519B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 11.08
Compugen (CGEN) Israel $0.465B 0.00
NantKwest (NK) United States $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Inovio Pharmaceuticals (INO) United States $0.442B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Mersana Therapeutics (MRSN) United States $0.419B 0.00
Cue Biopharma (CUE) United States $0.410B 0.00
Cel-Sci (CVM) United States $0.399B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
Merus (MRUS) Netherlands $0.392B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
Precision BioSciences (DTIL) United States $0.389B 0.00
PDL BioPharma (PDLI) United States $0.386B 9.66
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Pfenex (PFNX) United States $0.380B 0.00
Novavax (NVAX) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
Clovis Oncology (CLVS) United States $0.375B 0.00
Agenus (AGEN) United States $0.367B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.358B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.345B 0.00
Dynavax Technologies (DVAX) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Cellular Biomedicine (CBMG) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.303B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
Stemline Therapeutics (STML) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Syros Pharmaceuticals (SYRS) United States $0.282B 0.00
MannKind (MNKD) United States $0.278B 0.00
OSMOTICA PHARM (OSMT) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.269B 0.00
Kamada (KMDA) Israel $0.264B 10.96
Starpharma Holdings (SPHRY) Australia $0.257B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.256B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.247B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.239B 0.00
VBI Vaccines (VBIV) United States $0.234B 0.00
IVERIC Bio (ISEE) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.213B 0.00
XOMA (XOMA) United States $0.208B 0.00
Geron (GERN) United States $0.208B 0.00
Alcobra (ARCT) United States $0.204B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
VTv Therapeutics (VTVT) United States $0.203B 0.00
Prometic Life Sciences (LMNL) Canada $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Athersys (ATHX) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Affimed (AFMD) Germany $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Exicure (XCUR) United States $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.160B 8.23
Dyadic (DYAI) United States $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Selecta Biosciences (SELB) United States $0.153B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Verastem (VSTM) United States $0.142B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.139B 0.00
Aptinyx (APTX) United States $0.137B 0.00
VolitionRX (VNRX) Singapore $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
CorMedix Inc (CRMD) United States $0.133B 0.00
Arsanis (XFOR) United States $0.132B 0.00
Happiness Biotech Group (HAPP) China $0.129B 0.00
ARAVIVE, INC (ARAV) United States $0.128B 0.00
PHASEBIO PHARMA (PHAS) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Palatin Technologies (PTN) United States $0.106B 2.89
OvaScience (MLND) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Prima BioMed (IMMP) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Adocia (ADOCY) France $0.086B 0.00
Applied Genetic Technologies (AGTC) United States $0.085B 0.00
Proteostasis Therapeutics (PTI) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 4.29
Menlo Therapeutics (MNLO) United States $0.066B 0.00
IBio (IBIO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Trevena (TRVN) United States $0.061B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Curis (CRIS) United States $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
TOCAGEN INC (TOCA) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00